Back to search
FDAFDA · Food and drugs·Recall number D-1252-2014

Glycopyrrolate (MDV) 0.2 MG/ML Injectable, 5 mL Vials, Sterile Serum Vials/Sterile Syringes, for use by a licensed professional only, not for resale, MD Custom Rx, 19035 W Capitol Dr Ste 105, Brookfield, WI 53045.

Published April 30, 2014 · Recall initiated: November 13, 2013

Summary

FDA records drug Class I recall D-1252-2014, published April 30, 2014 and initiated November 13, 2013. Recalling firm: Brookfield Prescription Center Inc; Status: Terminated; Reported quantity: 25 Vials; Lot: Lot #: 10292013@15, Beyond Use Date: 11/28/2013. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thuringiensis.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Brookfield Prescription Center Inc
Distributor
WI
Lot
Lot #: 10292013@15, Beyond Use Date: 11/28/2013
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Glycopyrrolate (MDV) 0.2 MG/ML Injectable, 5 mL Vials, Sterile Serum Vials/Sterile Syringes, for use by a licensed professional only, not for resale, MD Custom Rx, 19035 W Capitol Dr Ste 105, Brookfield, WI 53045. recalled?

Yes. FDA published recall D-1252-2014 on April 30, 2014. Reported hazard: Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thuringiensis.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone